Arcadia Biosciences Cash Flow - Annual (NASDAQ:RKDA)

Add to My Stocks
$1.17 $0.04 (3.72%) RKDA stock closing price Dec 05, 2016 (Closing)

For analyzing any company like Arcadia Biosciences from an investment perspective, its important to check the cash flow statement. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Arcadia Biosciences profits and Arcadia Biosciences debt. This statement can tell if a company is running out of money while still being profitable and is useful in Arcadia Biosciences stock analysis. Arcadia Biosciences had a negative net income cash flow of $-17.95M for the latest year. This report is very useful in measuring the short term viability of a company. Arcadia Biosciences has a positive cash and cash equivalents change of $7.4M. View details of Arcadia Biosciences cash flows for latest & last ten financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Arcadia Biosciences Net Income Cash Flow
-17.95M-18.33M-13.19M
Depreciation Depletion Amortization Cash-Flow0.37M0.35M0.39M
Net Increase (Decrease) in Assets Liabilities-0.05M-1.33M-0.14M
Cash From (used in) Discontinued Operations---
Other Adjustments Net2.52M4.53M3.2M
Arcadia Biosciences Net Cash from (used by) Operating Activities
-15.1M-14.78M-9.74M
Increase (Decrease) in Prop Plant And Equipment-0.14M-0.14M-0.1M
Acquisition Disposition of Subsidiaires--1.45M-0.5M
Increase (Decrease) in Investments-46.21M--
Other Cash Inflow (Outflow) from Investment Activities---
Arcadia Biosciences Net Cash from (used by) Invesment Activities
-46.36M-1.59M-0.6M
Issuance (Purchase) of Equity Shares68.58M32.86M0.01M
Issuance (Repayment) of Debt Securities10.2M-1.15M7.83M
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities
Arcadia Biosciences Net Cash from (used by) Financing Activities
68.87M30.11M7.83M
Effect of Exchange Rate Changes on Cash---
Arcadia Biosciences Net Change in Cash & Cash Equivalents
7.4M13.73M-2.51M
Cash & Equivalents at Beginning of Year16.57M2.83M5.35M
Cash & Equivalents at Year End23.97M16.57M2.83M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Cash flow for another ticker

While Arcadia Biosciences stock price history provides the price history of a stock, Arcadia Biosciences stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Net Change in Cash and Cash Equivalents: Arcadia Biosciences cash grew YoY to $-17.95M, meaning the company is able to meet its expenditure and grow cash which will also eventually reflect in the Arcadia Biosciences stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Arcadia Biosciences lost $0.32M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: Arcadia Biosciences used $44.77M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $68.87M for Arcadia Biosciences. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.
.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin
-3.67